Undervalued Stocks Based On Cash Flows

Results

778

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

778 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
AXS
UK£0.71-0.3%18.3%UK£172.7mUK£1.1431.237.8%n/aMaterials
601567
CN¥15.68-2.7%-34.1%CN¥21.9bCN¥35.7723.145.6%4.0%Capital Goods
CTT
SEK 138.405.2%-34.1%SEK 1.7bn/a47.555.3%1.7%Capital Goods
DXRX
UK£1.45-3.3%5.1%UK£120.1mUK£2.131264.587.0%n/aPharmaceuticals & Biotech
P52
S$1.58-2.5%47.7%S$1.1bS$1.7021.812.5%2.8%Capital Goods
OCFC
US$19.15-3.6%8.6%US$1.9bUS$22.080.865.1%4.2%Banks
KOSKI
€8.501.2%-4.3%€204.8m€8.5038.443.4%1.6%Materials
LHV1T
€3.34-0.3%-5.8%€1.1b€4.401.521.1%5.1%Banks
CDG
€3.07-0.3%143.7%€28.7m€3.1746.437.4%1.1%Media
AEM
€6.440%10.1%€373.8m€7.3019.221.1%0.5%Media
MUR
zł39.100.5%-2.1%zł1.6bzł50.778.412.4%12.6%Real Estate Management and Development
STIL
SEK 233.00-0.4%3.1%SEK 2.1bSEK 285.7528.822.3%0%Healthcare
ALDMS
€1.08-1.4%-17.0%€27.9m€2.200.571.8%n/aHealthcare
AZN
UK£117.08-1.2%1.1%UK£181.5bUK£156.7023.513.7%2.0%Pharmaceuticals & Biotech
TEM
US$54.6116.9%-21.6%US$10.0bUS$62.646.945.0%n/aPharmaceuticals & Biotech
HSSEB
RM 0.53-2.8%-17.2%RM 269.5mRM 0.5917.337.6%2.8%Capital Goods
LITE
US$932.4712.9%675.6%US$72.7bUS$1,148.30188.236.7%n/aTech
VITR
SEK 91.853.4%-31.5%SEK 12.2bSEK 129.603.7103.8%1.2%Pharmaceuticals & Biotech
FLNC
US$13.20-7.2%74.8%US$2.4bUS$16.610.765.2%n/aCapital Goods
BRG
NOK 156.60-0.9%-23.6%NOK 15.5bNOK 178.2092.354.7%3.0%Materials
COA
UK£0.841.0%14.4%UK£1.6bUK£1.1919.016.9%2.9%Consumer Durables
PTEC
UK£3.732.1%-11.5%UK£1.0bUK£4.611.654.8%0%Consumer Services
MTK
€3.46-2.3%50.4%€34.1m€6.2067.250.7%n/aSoftware
WDAY
US$175.292.7%-21.4%US$44.8bUS$169.9751.123.4%n/aSoftware
Page 1 of 22
Undervalued Stocks Based On Cash Flows - Investing Ideas - Simply Wall St